日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The French Experience of Pharmacists and CAR T-Cells: A Study of the French Society of Oncology Pharmacy (SFPO)

法国药剂师与 CAR T 细胞疗法的经验:法国肿瘤药剂学会 (SFPO) 的一项研究

Schwiertz, Vérane; de Jorna, Romain; Quintard, Adeline; Lester, Marie-Antoinette; Pinturaud, Marine; Cormier, Nicolas; D'Huart, Elise; Fougereau, Emmanuelle; Carvalho, Muriel; Sourisseau, Benjamin; Gueneau, Pauline; Wasiak, Mathieu; Jouvance, Alexia; Paul, Muriel; Chevrier, Régine; Pourroy, Bertrand; Cazin, Jean-Louis; Ranchon, Florence; Madelaine-Chambrin, Isabelle; Rioufol, Catherine

Investigator-Initiated Clinical Pharmacokinetic Studies in Resource-Limited Settings: Minimal Requirements and Practical Guidance

资源匮乏环境下研究者发起的临床药代动力学研究:最低要求和实用指南

Uittenboogaard, Aniek; Mageto, Susan; Mohamed, Sherif Kamal Eldin; Pourroy, Bertrand; Mwesige, Benjamin; Chitedze, Agness Chisomo; Kaspers, Gertjan; Njuguna, Festus

Randomised controlled trial to assess the impact of hospital-community pharmaceutical care on drug-related problems in oncology practice for at-risk outpatients treated with oral anticancer drugs-a French Society for Oncology Pharmacy (SFPO) study: DROP-SFPO study protocol

一项随机对照试验,旨在评估医院-社区药学服务对接受口服抗癌药物治疗的高危肿瘤门诊患者药物相关问题的影响——法国肿瘤药学会 (SFPO) 研究:DROP-SFPO 研究方案

Ranchon, Florence; Huot, Laure; Bardin, Christophe; Madelaine, Isabelle; Cazin, Jean Louis; Pourroy, Bertrand; Tilleul, Patrick; Lemare, François; Rioufol, Catherine

Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated

预测细胞和基因疗法在法国的潜在影响:预测产品上市和接受治疗的患者人数

Lee, Ming Kei; Seyedmousavi, Sama; Auvity, Sylvain; Pourroy, Bertrand; Elleboode, Vincent; Kachaner, Isabelle; Jansen, Christel; Lilliu, Herve

Iron Oxide/Polymer Core-Shell Nanomaterials with Star-like Behavior

具有星状行为的氧化铁/聚合物核壳纳米材料

Virginie Vergnat, Benoît Heinrich, Michel Rawiso, René Muller, Geneviève Pourroy, Patrick Masson

Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)

癌症、免疫抑制和冠状病毒病-19 (COVID-19):需要管理药物安全(法国肿瘤药剂师协会 [SFPO] 指南)

Slimano, Florian; Baudouin, Amandine; Zerbit, Jérémie; Toulemonde-Deldicque, Anne; Thomas-Schoemann, Audrey; Chevrier, Régine; Daouphars, Mikaël; Madelaine, Isabelle; Pourroy, Bertrand; Tournamille, Jean-François; Astier, Alain; Ranchon, Florence; Cazin, Jean-Louis; Bardin, Christophe; Rioufol, Catherine

From 3D spheroids to tumor bearing mice: efficacy and distribution studies of trastuzumab-docetaxel immunoliposome in breast cancer.

从 3D 球体到荷瘤小鼠:曲妥珠单抗-多西他赛免疫脂质体在乳腺癌中的疗效和分布研究

Rodallec Anne, Sicard Guillaume, Giacometti Sarah, Carré Manon, Pourroy Bertrand, Bouquet Fanny, Savina Ariel, Lacarelle Bruno, Ciccolini Joseph, Fanciullino Raphaelle

Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progression

复发性神经外音猬因子髓母细胞瘤对维莫德吉和替莫唑胺单药治疗表现出持续反应,且在进展期存在转移灶间分子异质性

Petrirena, Gregorio J; Masliah-Planchon, Julien; Sala, Quentin; Pourroy, Bertrand; Frappaz, Didier; Tabouret, Emeline; Graillon, Thomas; Gentet, Jean-Claude; Delattre, Olivier; Chinot, Olivier; Padovani, Laetitia

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients

一种简单快速的西妥昔单抗治疗药物监测 LC-MS/MS 方法:针对头颈癌患者的 GPCO-UNICANCER 概念验证研究

François Becher, Joseph Ciccolini, Diane-Charlotte Imbs, Clémence Marin, Claire Fournel, Charlotte Dupuis, Nicolas Fakhry, Bertrand Pourroy, Aurélie Ghettas, Alain Pruvost, Christophe Junot, Florence Duffaud, Bruno Lacarelle, Sebastien Salas

Nanoparticles for imaging, sensing, and therapeutic intervention

用于成像、传感和治疗干预的纳米颗粒

Bogart, Lara K; Pourroy, Genevieve; Murphy, Catherine J; Puntes, Victor; Pellegrino, Teresa; Rosenblum, Daniel; Peer, Dan; Lévy, Raphaël